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Acute renal failure
Definition and detection







Acute Kidney Injury (AKI)
Definition
Sudden decline in GFR and so 
- Decrease in toxins excretion
- Maintain the volemic and ionic 
equilibrium
 Relatively few symptoms (except 
olguria), so we need for the lab
Definition, classification





• The goal is not to evaluate RENAL FUNCTION 
per se
• To capture AKI prognosis (mortality and RRT) 
through serum creatinine changes
• BACK CALCULATION OF BASELINE CREATININE 
(overestimation of AKI)
Definition
Criteria to define AKI
Diuresis and especially oliguria (<500ml/24h) remains specific
-Depend on perfusion and diuretics
-ARF with conserved diuresis 
239 ICU patients
Oliguria vs. AKI according to Screat. 
Incidence of AKI-Screat: 13.4%
6 hours of oliguria :
Sensitivity : 21%
Specificity : 93%
Positive predictive value : 9%
Negative predictive value : 97%
Definition
• Creatinine
• New ARF biomarkers (cystatin C) and/or new AKI 
biomarkers (NGAL, KIM1, IL18….)
Serum creatinine: Analytical limitations
• Jaffe: Pseudochromogen: glucose, fructose, 
ascorbate, proteins, urate, acetoacetate, acetone, 
pyruvate => false « high » 
• Bilirubins: false « low »
• Few (fewer) interferences with enzymatic 
methods
• Different Jaffe-Enzymatic methods, different 
calibration by different manufacturers
• IDMS-traceability (enzymatic methods)
Serum creatinine: Physiological limitations
• Production (relatively) constant but muscular production => 






• Tubular secretion of creatinine
• 10 to 40%
• Increase with decreased GFR
• Unpredictable at the individual level 
Perrone RD, Clin Chem, 1992, p1933
eGFR equations
CYSTATIN C
• cystéine protéase inhibitor(13 kDa)
• Produced by all nucleated cells (housekeeping
gene)
• Freely filtrated through the glomerulus
• Fully reabsorbed and metabolized by the 
tubules
• Standardisation is possible (ERM-DA471/IFCC)
• Not influenced by muscular mass
47 patients
hemodynamiccaly stable
Avec Scr <1,5 mg/dL
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Herget-Rosenthal et al., Kidney Int 2004    85 adultes, general ICU, S-creatinine rise > 50%
DETECTION OF AKI
Cystatin C
• Potentially of interest
• Relatively few studies
• There are also non-GFR determinants of 
cystatin C
• More expensive
• Cost-effectiveness not definitively proven
What about eGFR equations?
















• Good correlation: a “sine qua non” condition but insufficient
• Bias: mean difference between two values = the systematic error
• Precision: SD around the bias = the random error
• Accuracy 30% = % of eGFR between ± 30% of measured GFR

- Kinetic eGFR: to analyze kidney function in the acute 
setting
- Initial creatinine content, Vd, creatinine production rate 
and the quantitative difference between consecutive 
Scr over a short period of time
Kinetic GFR
SSPCr= baseline creatinine (the lowest known for the patient)
CrCl= MDRD or CKD-EPI
Mean PCr= mean of considered creatinine
ΔPCr= changes in creatinine
Δtime=interval in hours between two creatinine 
ΔMaxPcr=the maximal change (increase) in the plasma creatinine that 




• Monitoring diuresis and serum creatinine
• Cystatin C: maybe of interest 
• eGFR equations lack of precision
• Kinetic eGFR: simple, based on creatinine, but 
need to be validated in future studies
• Now we are moving from acute renal failure 
detection/monitoring to acute kidney injury 
